Muna Al Maslamani

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Maryam Al‐Nesf, Houari Abdesselem, Ilham Bensmail et al. · Nature Communications · 2022 · 86 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

Ali S. Omrani, Sameer A. Pathan, Sarah A. Thomas et al. · EClinicalMedicine · 2020 · 73 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Discovery of <i>mcr-1</i> -Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage

Brian M. Forde, Hosam M. Zowawi, Patrick N. A. Harris et al. · mSphere · 2018 · 67 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

Anand Deshmukh, Ferry Hagen, Ola Al Sharabasi et al. · BMC Microbiology · 2015 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report

Hussam Al Soub, Wanis Ibrahim, Muna Al Maslamani et al. · IDCases · 2021 · 37 citations · Full text

Medicine, Infectious Diseases, Pathology +13